Cover Image

A multicenter open-label phase II trial to evaluate nivolumab and ipilimumab for 2nd line therapy in elderly patients with advanced esophageal squamous cell cancer (RAMONA)

Show other versions (1)

Advanced esophageal squamous cell cancer (ESCC) is frequently diagnosed in elderly patients. The impact of 2nd line chemotherapy is poorly defined. Recent data demonstrated effectiveness of checkpoint inhibitors in different squamous cell carcinomas. Therefore, we assess combined nivolumab/ipilimuma...

Full description

Saved in:
Bibliographic Details
Main Authors: Meindl-Beinker, Nadja M. (Author) , Betge, Johannes (Author) , Gutting, Tobias (Author) , Burgermeister, Elke (Author) , Belle, Sebastian (Author) , Zhan, Tianzuo (Author) , Schulte, Nadine (Author) , Ebert, Matthias (Author) , Härtel, Nicolai (Author)
Format: Article (Journal)
Language:English
Published: 14 March 2019
In: BMC cancer
Year: 2019, Volume: 19
ISSN:1471-2407
DOI:10.1186/s12885-019-5446-2
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.1186/s12885-019-5446-2
Get full text
Author Notes:Nadja M. Meindl-Beinker, Johannes Betge, Tobias Gutting, Elke Burgermeister, Sebastian Belle, Tianzuo Zhan, Nadine Schulte, Martin Maenz, Matthias P. Ebert and Nicolai Haertel
Search Result 1
Cover Image

A multicenter open-label phase II trial to evaluate nivolumab and ipilimumab for 2nd line therapy in elderly patients with advanced esophageal squamous cell cancer (RAMONA) by Meindl-Beinker, Nadja M. (Author) , Betge, Johannes (Author) , Gutting, Tobias (Author) , Burgermeister, Elke (Author) , Belle, Sebastian (Author) , Zhan, Tianzuo (Author) , Schulte, Nadine (Author) , Ebert, Matthias (Author) , Härtel, Nicolai (Author) ,

BioMed Central ; Springer 21 Mai 2019 Universitätsbibliothek Heidelberg 21 Mai 2019

Get full text
Article (Journal) Book/Monograph Online Resource

Saved in:
Show all versions (2)

Similar Items